Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV) - PubMed (original) (raw)

Case Reports

Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV)

Brittany L Murray et al. J Med Toxicol. 2012 Mar.

Abstract

Introduction: 3,4-Methylenedioxypyrovalerone (MDPV) is a designer stimulant drug that has gained popularity in the USA. Although adverse effects of MDPV have been described, to our knowledge, this is the first reported death.

Case report: We report the case of a 40-year-old male who injected and snorted "bath salts" containing MDPV and subsequently became agitated, aggressive, and experienced a cardiac arrest. He was resuscitated after his initial arrest; however, he developed hyperthermia, rhabdomyolysis, coagulopathy, acidosis, anoxic brain injury, and subsequently died.

Discussion: This is the first case in the medical literature to report death due to isolated confirmed MDPV intoxication. The manner of death is also consistent with excited delirium syndrome.

PubMed Disclaimer

Figures

Fig. 1

Chemical structures of 3,4-methylenedioxypyrovalerone (MDPV); cathinone; 3,4-methylenedioxymethamphetamine (MDMA); and pyrovalerone

Fig. 2

a Initial prehospital EKG. b Repeat prehospital EKG performed 10 min later demonstrating normal sinus rhythm with rate of 85 bpm, PR interval 110 msec, QRS interval 116 msec, QTc interval 414 msec, and peaked T waves

Fig. 3

Post-arrest EKG

Fig. 4

EKG after treatment for hyperkalemia. PR interval of 125 msec, QRS interval of 83 msec, QTc interval of 412 msec, normalization of the T waves and ST depressions in leads II and III with mild ST elevation in leads V1 and V2

Cited by

The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?
Meyers K, Kaynak Ö, Bresani E, Curtis B, McNamara A, Brownfield K, Kirby KC. Meyers K, et al. Int J Drug Policy. 2015 Jul;26(7):670-4. doi: 10.1016/j.drugpo.2015.01.012. Epub 2015 Jan 16. Int J Drug Policy. 2015. PMID: 25641258 Free PMC article.
"Bath salts" and "plant food" products: the experience of one regional US poison center.
Murphy CM, Dulaney AR, Beuhler MC, Kacinko S. Murphy CM, et al. J Med Toxicol. 2013 Mar;9(1):42-8. doi: 10.1007/s13181-012-0243-1. J Med Toxicol. 2013. PMID: 22733603 Free PMC article.
Sensitization to the motor stimulant effects of 3,4-methylenedioxypyrovalerone (MDPV) and cross-sensitization to methamphetamine in rats.
Watterson LR, Kufahl PR, Taylor SB, Nemirovsky NE, Olive MF. Watterson LR, et al. J Drug Alcohol Res. 2016 May;5:235967. doi: 10.4303/jdar/235967. J Drug Alcohol Res. 2016. PMID: 27284493 Free PMC article.
Abuse potential and toxicity of the synthetic cathinones (i.e., "Bath salts").
Riley AL, Nelson KH, To P, López-Arnau R, Xu P, Wang D, Wang Y, Shen HW, Kuhn DM, Angoa-Perez M, Anneken JH, Muskiewicz D, Hall FS. Riley AL, et al. Neurosci Biobehav Rev. 2020 Mar;110:150-173. doi: 10.1016/j.neubiorev.2018.07.015. Epub 2019 May 14. Neurosci Biobehav Rev. 2020. PMID: 31101438 Free PMC article. Review.
'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.
Smith CD, Robert S. Smith CD, et al. Clin Med (Lond). 2014 Aug;14(4):409-15. doi: 10.7861/clinmedicine.14-4-409. Clin Med (Lond). 2014. PMID: 25099844 Free PMC article. Review.

References

1. Spiller H, Ryan M, Weston R, Jansen J. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol. 2011;49(6):499–505. doi: 10.3109/15563650.2011.590812. - DOI - PubMed
1. Yohannan J, Bozenko J. The characterization of 3,4-methylenedioxypyrovalerone (MDVP) Microgram Journal. 2010;7:21–15.
1. 1-[(3, 4-Methylenedioxy)phenyl]-2-pyrrolidino-1 alkanones as stimulants (1969) Boehringer Ingelheim Study
1. Westphal F, Junge T, Rösner P, Sönnichsen F, Schuster F. Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure. Forensic Sci Int. 2009;190(1–3):1–8. doi: 10.1016/j.forsciint.2009.05.001. - DOI - PubMed
1. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y. Analysis of designer drugs detected in the products purchased in fiscal year 2006. Yakugaku Zasshi. 2008;128(10):1499–1505. doi: 10.1248/yakushi.128.1499. - DOI - PubMed

Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV) - PubMed (original) (raw)